{"entity":{"type":"insider","cik":"0001400973","url":"/insider/0001400973","json_url":"/insider/0001400973.json","name":"Crowley John F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":394,"n_filings":150,"first":"2008-01-04","last":"2024-03-15","span_basis":"filed_date"},"name_variants":[{"name":"Crowley John F","source":"filing","n_filings":150,"first_seen":"2008-01-04","last_seen":"2024-03-15"}],"transactions":[{"id":2387062,"accession":"0000950170-24-026265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-026265","line_url":"/filing/0000950170-24-026265#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29181.0,"shares_display":"29,181","price_per_share":13.3492,"price_display":"13.35","price_state":"stated","total_value":389543.0052,"total_display":"389,543.01","total_whole":"389,543","shares_owned_after":573478.0,"shares_owned_after_display":"573,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":2080597,"accession":"0000950170-24-017264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-017264","line_url":"/filing/0000950170-24-017264#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31614.0,"shares_display":"31,614","price_per_share":13.8088,"price_display":"13.81","price_state":"stated","total_value":436551.4032,"total_display":"436,551.40","total_whole":"436,551","shares_owned_after":697628.0,"shares_owned_after_display":"697,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":2733893,"accession":"0000950170-24-011433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-011433","line_url":"/filing/0000950170-24-011433#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31614.0,"shares_display":"31,614","price_per_share":12.6184,"price_display":"12.62","price_state":"stated","total_value":398918.0976,"total_display":"398,918.10","total_whole":"398,918","shares_owned_after":750838.0,"shares_owned_after_display":"750,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":2234699,"accession":"0000950170-24-007065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-007065","line_url":"/filing/0000950170-24-007065#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55327.0,"shares_display":"55,327","price_per_share":12.3621,"price_display":"12.36","price_state":"stated","total_value":683957.9067,"total_display":"683,957.91","total_whole":"683,958","shares_owned_after":782452.0,"shares_owned_after_display":"782,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":2115184,"accession":"0000950170-24-005451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-005451","line_url":"/filing/0000950170-24-005451#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31614.0,"shares_display":"31,614","price_per_share":12.7825,"price_display":"12.78","price_state":"stated","total_value":404105.955,"total_display":"404,105.96","total_whole":"404,106","shares_owned_after":837779.0,"shares_owned_after_display":"837,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":2459693,"accession":"0000950170-24-032406","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-032406","line_url":"/filing/0000950170-24-032406#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31614.0,"shares_display":"31,614","price_per_share":13.6475,"price_display":"13.65","price_state":"stated","total_value":431452.065,"total_display":"431,452.06","total_whole":"431,452","shares_owned_after":927013.0,"shares_owned_after_display":"927,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-03-15","scope":"insider"},{"id":2458192,"accession":"0000950170-24-004042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-004042","line_url":"/filing/0000950170-24-004042#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31614.0,"shares_display":"31,614","price_per_share":13.6475,"price_display":"13.65","price_state":"stated","total_value":431452.065,"total_display":"431,452.06","total_whole":"431,452","shares_owned_after":869393.0,"shares_owned_after_display":"869,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-11","scope":"insider"},{"id":8065371,"accession":"0000950170-23-071631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071631","line_url":"/filing/0000950170-23-071631#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6043.0,"shares_display":"6,043","price_per_share":12.6619,"price_display":"12.66","price_state":"stated","total_value":76515.8617,"total_display":"76,515.86","total_whole":"76,516","shares_owned_after":877748.0,"shares_owned_after_display":"877,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-19","scope":"insider"},{"id":8108747,"accession":"0000950170-23-068254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-068254","line_url":"/filing/0000950170-23-068254#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6043.0,"shares_display":"6,043","price_per_share":11.08,"price_display":"11.08","price_state":"stated","total_value":66956.44,"total_display":"66,956.44","total_whole":"66,956","shares_owned_after":883791.0,"shares_owned_after_display":"883,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":8530701,"accession":"0000950170-23-064910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064910","line_url":"/filing/0000950170-23-064910#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6043.0,"shares_display":"6,043","price_per_share":10.8385,"price_display":"10.84","price_state":"stated","total_value":65497.0555,"total_display":"65,497.06","total_whole":"65,497","shares_owned_after":889834.0,"shares_owned_after_display":"889,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":7940284,"accession":"0000950170-23-058953","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-058953","line_url":"/filing/0000950170-23-058953#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":10.9741,"price_display":"10.97","price_state":"stated","total_value":66327.4604,"total_display":"66,327.46","total_whole":"66,327","shares_owned_after":895877.0,"shares_owned_after_display":"895,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8621125,"accession":"0000950170-23-054012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-054012","line_url":"/filing/0000950170-23-054012#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":10.4979,"price_display":"10.50","price_state":"stated","total_value":63449.3076,"total_display":"63,449.31","total_whole":"63,449","shares_owned_after":901921.0,"shares_owned_after_display":"901,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"},{"id":8335116,"accession":"0001209191-23-052110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-052110","line_url":"/filing/0001209191-23-052110","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.245379880873594,"price_display":"11.25","price_state":"stated","total_value":67967.076,"total_display":"67,967.08","total_whole":"67,967","shares_owned_after":909565.0,"shares_owned_after_display":"909,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider","n_lines":2},{"id":8547017,"accession":"0001209191-23-049782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049782","line_url":"/filing/0001209191-23-049782#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":13.0648,"price_display":"13.06","price_state":"stated","total_value":78963.6512,"total_display":"78,963.65","total_whole":"78,964","shares_owned_after":914009.0,"shares_owned_after_display":"914,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8189700,"accession":"0001209191-23-048461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048461","line_url":"/filing/0001209191-23-048461#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":12.9794,"price_display":"12.98","price_state":"stated","total_value":78447.4936,"total_display":"78,447.49","total_whole":"78,447","shares_owned_after":920053.0,"shares_owned_after_display":"920,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":7836254,"accession":"0001209191-23-046081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046081","line_url":"/filing/0001209191-23-046081#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":13.0268,"price_display":"13.03","price_state":"stated","total_value":78733.9792,"total_display":"78,733.98","total_whole":"78,734","shares_owned_after":926097.0,"shares_owned_after_display":"926,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-16","scope":"insider"},{"id":8221746,"accession":"0001209191-23-044494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-044494","line_url":"/filing/0001209191-23-044494#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":13.3548,"price_display":"13.35","price_state":"stated","total_value":80716.4112,"total_display":"80,716.41","total_whole":"80,716","shares_owned_after":932141.0,"shares_owned_after_display":"932,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8295470,"accession":"0001209191-23-042773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042773","line_url":"/filing/0001209191-23-042773#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":13.4453,"price_display":"13.45","price_state":"stated","total_value":81263.3932,"total_display":"81,263.39","total_whole":"81,263","shares_owned_after":938185.0,"shares_owned_after_display":"938,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8703762,"accession":"0001209191-23-041658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041658","line_url":"/filing/0001209191-23-041658#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":12.3107,"price_display":"12.31","price_state":"stated","total_value":74405.8708,"total_display":"74,405.87","total_whole":"74,406","shares_owned_after":944229.0,"shares_owned_after_display":"944,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":8680059,"accession":"0001209191-23-038515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038515","line_url":"/filing/0001209191-23-038515#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":13.04,"price_display":"13.04","price_state":"stated","total_value":78813.76,"total_display":"78,813.76","total_whole":"78,814","shares_owned_after":950273.0,"shares_owned_after_display":"950,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":8439060,"accession":"0001209191-23-034638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034638","line_url":"/filing/0001209191-23-034638#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.3596,"price_display":"11.36","price_state":"stated","total_value":68657.4224,"total_display":"68,657.42","total_whole":"68,657","shares_owned_after":956317.0,"shares_owned_after_display":"956,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider"},{"id":8723680,"accession":"0001209191-23-030378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030378","line_url":"/filing/0001209191-23-030378#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.1808,"price_display":"11.18","price_state":"stated","total_value":67576.7552,"total_display":"67,576.76","total_whole":"67,577","shares_owned_after":962361.0,"shares_owned_after_display":"962,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8532126,"accession":"0001062993-23-010103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-010103","line_url":"/filing/0001062993-23-010103#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.8026,"price_display":"11.80","price_state":"stated","total_value":71334.9144,"total_display":"71,334.91","total_whole":"71,335","shares_owned_after":968405.0,"shares_owned_after_display":"968,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":7968871,"accession":"0001209191-23-024884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-024884","line_url":"/filing/0001209191-23-024884#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.6648,"price_display":"11.66","price_state":"stated","total_value":70502.0512,"total_display":"70,502.05","total_whole":"70,502","shares_owned_after":974449.0,"shares_owned_after_display":"974,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":8019659,"accession":"0001209191-23-023529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023529","line_url":"/filing/0001209191-23-023529#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.2156,"price_display":"11.22","price_state":"stated","total_value":67787.0864,"total_display":"67,787.09","total_whole":"67,787","shares_owned_after":980493.0,"shares_owned_after_display":"980,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":7994880,"accession":"0001209191-23-019892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-019892","line_url":"/filing/0001209191-23-019892#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":11.3414,"price_display":"11.34","price_state":"stated","total_value":68547.4216,"total_display":"68,547.42","total_whole":"68,547","shares_owned_after":986537.0,"shares_owned_after_display":"986,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-17","scope":"insider"},{"id":8288773,"accession":"0001209191-23-015842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-015842","line_url":"/filing/0001209191-23-015842","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":13.417111317008603,"price_display":"13.42","price_state":"stated","total_value":81093.0208,"total_display":"81,093.02","total_whole":"81,093","shares_owned_after":994518.0,"shares_owned_after_display":"994,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider","n_lines":2},{"id":7830503,"accession":"0001209191-23-010214","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010214","line_url":"/filing/0001209191-23-010214#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6044.0,"shares_display":"6,044","price_per_share":12.9413,"price_display":"12.94","price_state":"stated","total_value":78217.2172,"total_display":"78,217.22","total_whole":"78,217","shares_owned_after":998625.0,"shares_owned_after_display":"998,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-16","scope":"insider"},{"id":8701317,"accession":"0001209191-23-007119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-007119","line_url":"/filing/0001209191-23-007119#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147316.0,"shares_display":"147,316","price_per_share":13.1102,"price_display":"13.11","price_state":"stated","total_value":1931342.2232,"total_display":"1,931,342.22","total_whole":"1,931,342","shares_owned_after":1004669.0,"shares_owned_after_display":"1,004,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":7966797,"accession":"0001209191-23-003083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003083","line_url":"/filing/0001209191-23-003083#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85102.0,"shares_display":"85,102","price_per_share":11.4328,"price_display":"11.43","price_state":"stated","total_value":972954.1456,"total_display":"972,954.15","total_whole":"972,954","shares_owned_after":885229.0,"shares_owned_after_display":"885,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6549182,"accession":"0001209191-22-062014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062014","line_url":"/filing/0001209191-22-062014#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":12.1486,"price_display":"12.15","price_state":"stated","total_value":127171.5448,"total_display":"127,171.54","total_whole":"127,172","shares_owned_after":791454.0,"shares_owned_after_display":"791,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6435499,"accession":"0001209191-22-059829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059829","line_url":"/filing/0001209191-22-059829#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11347.0,"shares_display":"11,347","price_per_share":12.2035,"price_display":"12.20","price_state":"stated","total_value":138473.1145,"total_display":"138,473.11","total_whole":"138,473","shares_owned_after":801922.0,"shares_owned_after_display":"801,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6575013,"accession":"0001209191-22-057594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057594","line_url":"/filing/0001209191-22-057594#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":11.6418,"price_display":"11.64","price_state":"stated","total_value":121866.3624,"total_display":"121,866.36","total_whole":"121,866","shares_owned_after":813269.0,"shares_owned_after_display":"813,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6787901,"accession":"0001209191-22-055675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055675","line_url":"/filing/0001209191-22-055675#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11346.0,"shares_display":"11,346","price_per_share":10.3166,"price_display":"10.32","price_state":"stated","total_value":117052.1436,"total_display":"117,052.14","total_whole":"117,052","shares_owned_after":823737.0,"shares_owned_after_display":"823,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6613722,"accession":"0001209191-22-054130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054130","line_url":"/filing/0001209191-22-054130#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":10.9045,"price_display":"10.90","price_state":"stated","total_value":114148.306,"total_display":"114,148.31","total_whole":"114,148","shares_owned_after":835083.0,"shares_owned_after_display":"835,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-19","scope":"insider"},{"id":6212706,"accession":"0001209191-22-052856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052856","line_url":"/filing/0001209191-22-052856#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11346.0,"shares_display":"11,346","price_per_share":10.7462,"price_display":"10.75","price_state":"stated","total_value":121926.3852,"total_display":"121,926.39","total_whole":"121,926","shares_owned_after":845551.0,"shares_owned_after_display":"845,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6536112,"accession":"0001062993-22-019752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-019752","line_url":"/filing/0001062993-22-019752#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":10.6637,"price_display":"10.66","price_state":"stated","total_value":111627.6116,"total_display":"111,627.61","total_whole":"111,628","shares_owned_after":856897.0,"shares_owned_after_display":"856,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6330674,"accession":"0001209191-22-048794","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-048794","line_url":"/filing/0001209191-22-048794#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11346.0,"shares_display":"11,346","price_per_share":11.2958,"price_display":"11.30","price_state":"stated","total_value":128162.1468,"total_display":"128,162.15","total_whole":"128,162","shares_owned_after":867365.0,"shares_owned_after_display":"867,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6185674,"accession":"0001209191-22-046399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-046399","line_url":"/filing/0001209191-22-046399#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":12.2836,"price_display":"12.28","price_state":"stated","total_value":128584.7248,"total_display":"128,584.72","total_whole":"128,585","shares_owned_after":878711.0,"shares_owned_after_display":"878,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6699580,"accession":"0001209191-22-044343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044343","line_url":"/filing/0001209191-22-044343#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11346.0,"shares_display":"11,346","price_per_share":9.962,"price_display":"9.96","price_state":"stated","total_value":113028.852,"total_display":"113,028.85","total_whole":"113,029","shares_owned_after":889179.0,"shares_owned_after_display":"889,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6631147,"accession":"0001209191-22-042597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042597","line_url":"/filing/0001209191-22-042597#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":10.8592,"price_display":"10.86","price_state":"stated","total_value":113674.1056,"total_display":"113,674.11","total_whole":"113,674","shares_owned_after":900525.0,"shares_owned_after_display":"900,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":6892665,"accession":"0001209191-22-041399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041399","line_url":"/filing/0001209191-22-041399#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11346.0,"shares_display":"11,346","price_per_share":10.7824,"price_display":"10.78","price_state":"stated","total_value":122337.1104,"total_display":"122,337.11","total_whole":"122,337","shares_owned_after":910993.0,"shares_owned_after_display":"910,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6276543,"accession":"0001209191-22-038009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038009","line_url":"/filing/0001209191-22-038009#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10468.0,"shares_display":"10,468","price_per_share":8.0091,"price_display":"8.01","price_state":"stated","total_value":83839.2588,"total_display":"83,839.26","total_whole":"83,839","shares_owned_after":922339.0,"shares_owned_after_display":"922,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-17","scope":"insider"},{"id":6390738,"accession":"0001209191-22-034894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034894","line_url":"/filing/0001209191-22-034894#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11346.0,"shares_display":"11,346","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":90768.0,"total_display":"90,768.00","total_whole":"90,768","shares_owned_after":932807.0,"shares_owned_after_display":"932,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6429929,"accession":"0001209191-22-031930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-031930","line_url":"/filing/0001209191-22-031930#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21814.0,"shares_display":"21,814","price_per_share":8.0025,"price_display":"8.00","price_state":"stated","total_value":174566.535,"total_display":"174,566.54","total_whole":"174,567","shares_owned_after":944153.0,"shares_owned_after_display":"944,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":6250814,"accession":"0001209191-22-025052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-025052","line_url":"/filing/0001209191-22-025052#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8254.0,"shares_display":"8,254","price_per_share":8.0061,"price_display":"8.01","price_state":"stated","total_value":66082.3494,"total_display":"66,082.35","total_whole":"66,082","shares_owned_after":965967.0,"shares_owned_after_display":"965,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-20","scope":"insider"},{"id":6250811,"accession":"0001209191-22-025052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025052","line_url":"/filing/0001209191-22-025052#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2214.0,"shares_display":"2,214","price_per_share":8.0371,"price_display":"8.04","price_state":"stated","total_value":17794.1394,"total_display":"17,794.14","total_whole":"17,794","shares_owned_after":974221.0,"shares_owned_after_display":"974,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-20","scope":"insider"},{"id":6888973,"accession":"0001209191-22-003820","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-003820","line_url":"/filing/0001209191-22-003820#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400973","owner_name":"Crowley John F","owner_display_name":"Crowley John F","owner_url":"/insider/0001400973","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8564.0,"shares_display":"8,564","price_per_share":10.23,"price_display":"10.23","price_state":"stated","total_value":87609.72,"total_display":"87,609.72","total_whole":"87,610","shares_owned_after":976435.0,"shares_owned_after_display":"976,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-19","scope":"insider"}],"collapsed":true,"next_cursor":"2022-01-18|6888973","ledger_fault":false,"count":{"value":394,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":388,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":394},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Director, Officer (Executive Chairman)","n_filings":147,"first_seen":"2008-01-04","last_seen":"2024-03-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Director","n_filings":1,"first_seen":"2022-01-13","last_seen":"2022-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Director","n_filings":2,"first_seen":"2021-10-07","last_seen":"2021-10-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001400973","retrieved_at":"2026-08-24T02:14:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}